Stocks and Investing Stocks and Investing
Fri, July 16, 2021

Gil Blum Initiated (TSHA) at Strong Buy and Held Target at $45 on, Jul 16th, 2021


Published on 2024-10-27 17:13:32 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $45 on, Jul 16th, 2021.

Gil has made no other calls on TSHA in the last 4 months.



There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Gil


  • Joon Lee of "Truist Securities" Initiated at Strong Buy and Held Target at $60 on, Thursday, June 24th, 2021
  • Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $44 on, Tuesday, June 15th, 2021
  • Laura Chico of "Wedbush" Initiated at Buy and Held Target at $31 on, Wednesday, June 9th, 2021
  • Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $40 on, Tuesday, June 8th, 2021
  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Wednesday, May 19th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $43 on, Tuesday, April 13th, 2021
  • Gbola Amusa of "Chardan Capital" Maintained at Strong Buy with Increased Target to $68 on, Tuesday, April 13th, 2021
Contributing Sources